{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["21(1)"],"submitter":["Chen Q"],"pubmed_abstract":["<h4>Background</h4>Never in mitosis gene-A (NIMA)-related expressed kinase 2 (NEK2) is a serine/threonine protein kinase regulated by the cell cycle. The purpose of this study was to obtain NEK2 protein to prepare an anti-NEK2 monoclonal antibody (mAb) and explore the application of the anti-NEK2 mAb of therapeutic and diagnostic in hepatocellular carcinoma (HCC).<h4>Results</h4>The NEK2 gene sequence was cloned from the normal liver cell line HL7702, and the full-length NEK2 gene sequence was cloned into the prokaryotic expression vector pET30a and transformed into Escherichia coli BL21 (DE3) cells. The recombinant fusion protein was obtained under optimized conditions and injected in BALB/c mice to prepare an anti-NEK2 mAb. By screening, we obtained a stable hybridoma cell line named 3A3"],"journal":["BMC biotechnology"],"pagination":["62"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8549277"],"repository":["biostudies-literature"],"pubmed_title":["Preparation of an anti-NEK2 monoclonal antibody and its application in liver cancer."],"pmcid":["PMC8549277"],"pubmed_authors":["Li G","Li H","Chen Q","Liu J","Yang L","Guo X","Huang X","He M","Wen S","Hu B"],"additional_accession":[]},"is_claimable":false,"name":"Preparation of an anti-NEK2 monoclonal antibody and its application in liver cancer.","description":"<h4>Background</h4>Never in mitosis gene-A (NIMA)-related expressed kinase 2 (NEK2) is a serine/threonine protein kinase regulated by the cell cycle. The purpose of this study was to obtain NEK2 protein to prepare an anti-NEK2 monoclonal antibody (mAb) and explore the application of the anti-NEK2 mAb of therapeutic and diagnostic in hepatocellular carcinoma (HCC).<h4>Results</h4>The NEK2 gene sequence was cloned from the normal liver cell line HL7702, and the full-length NEK2 gene sequence was cloned into the prokaryotic expression vector pET30a and transformed into Escherichia coli BL21 (DE3) cells. The recombinant fusion protein was obtained under optimized conditions and injected in BALB/c mice to prepare an anti-NEK2 mAb. By screening, we obtained a stable hybridoma cell line named 3A3","dates":{"release":"2021-01-01T00:00:00Z","publication":"2021 Oct","modification":"2025-04-18T19:10:53.984Z","creation":"2025-04-07T06:52:48.49Z"},"accession":"S-EPMC8549277","cross_references":{"pubmed":["34706700"],"doi":["10.1186/s12896-021-00717-3"]}}